Spain weighs millions for transplants and rare diseases
Fifty-point-two million euros for marrow donation, staff training and transplant safety: Spain’s health council weighs how to share the funding between autonomous communities on Friday, 23 October. The Interterritorial Council of Spain’s National Health System also considers funding for rare diseases and plasma donation, alongside common rules for waiting-list information. These are proposals on the agenda, not money already allocated to Mallorca or elsewhere.
Funding for rare diseases and plasma
The council will examine a proposed €2,818,070 for strategies covering rare and neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Another €2 million would go towards improving the health system’s supply of human plasma. A separate €5 million proposal covers monitoring systems and equipment for plasma donation units.
Proposed funding also includes €3 million for health protection and prevention, and €7 million for monitoring areas including cancer, rare diseases and mental health.
Waiting lists and patient care
Beyond the funding, the council will consider common standards for reporting waiting-list information. It will also review recommendations on moving patients with chronic conditions from children’s to adult care, and criteria for assigning patients to proton therapy.
One decision on the agenda concerns whether to join the Declaration of Menorca, which addresses emotional wellbeing and mental health protection for migrant children and teenagers.
Source: Europa Press / Mallorca.com